Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancer

Purpose: Expression of the type 1 insulin-like growth factor receptor (IGF1R) confers adverse prognosis in clear cell renal cell cancer (CC-RCC). We recently showed that IGF1R expression is inhibited by the von Hippel-Lindau (VHL) tumor suppressor, and the IGF1R is up-regulated in CC-RCC, in which V...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Yuen, J, Akkaya, E, Wang, Y, Takiguchi, M, Peak, S, Sullivan, M, Protheroe, A, Macaulay, V
Fformat: Journal article
Iaith:English
Cyhoeddwyd: 2009